Patients Deserve Accurate Drug Pricing Data

House Committee on Energy and Commerce · February 18, 2026

0:00/1m

1:05

0:00

0:30

1:00

Overview of supply-chain accountability and data gaps

PresentationPresentation

0:00 → 1:05(1m 5s)

Unidentified Speaker (witness) said a consistent theme in the prescription drug supply chain is mutual blame among manufacturers, PBMs, wholesalers and plan sponsors and that no party alone explains high prices. The witness named specific targets of blame: manufacturers point to PBMs and rebate structures; PBMs point to manufacturer list price and pharmacy reimbursement; wholesalers blamed contracting dynamics; plan sponsors said they lacked visibility. The witness emphasized that "congress, employers, and patients still do not have access to transactional level price data," arguing that this缺

Keywords:

Speakers:Unidentified Speaker

An unidentified witness testified that actors across the prescription drug supply chain blame one another for high prices and that congressional, employer and patient access to transactional-level price data is lacking, preventing accountability for rising costs.

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Transcript

Unlock the transcript with a paid subscription